Oncology Institute Inc (TOI) Peer Comparison
$6.20
$1.17
(23.26%)
As on 11-Aug-2026 09:30EDT
Market cap
$513 Mln
Revenue (TTM)
$546 Mln
P/E Ratio
--
P/B Ratio
0.8
Div. Yield
0 %
Edit
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
513 | 12,015 | 9,954 | 6,491 | 6,794 |
Revenue ($ Mln) |
546 | 6,206 | 5,487 | 2,578 | 2,595 |
Net Profit ($ Mln) |
-43.51 | 621.00 | 378.70 | -142.03 | 274.99 |
Net Margin (%) |
-7.97 | 10.01 | 6.90 | -5.51 | 10.60 |
RoE (%) |
-- | 16.23 | 16.18 | -32.84 | 30.39 |
Price to Earnings |
-- | 20.33 | 26.77 | -- | 26.15 |
Price-To-Book |
0.76 | 4.60 | 4.11 | 20.48 | 8.25 |
Income Statement ($ Mln)
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
545.76 | 6,206.10 | 5,486.71 | 2,578.11 | 2,595.00 |
|
Cost of Revenue
|
464.88 | 1,733.50 | 4,710.80 | 910.53 | 1,805.04 |
|
Gross Profit
|
76.44 | 5,680.80 | 799.45 | 1,733.38 | 758.34 |
|
Operating Expenses
|
113.57 | 3,421.70 | 308.52 | 1,760.25 | 440.80 |
|
Operating Profit (EBIT)
|
-32.69 | 1,117.00 | 467.39 | -92.67 | 349.19 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-43.64 | 1,027.90 | 498.93 | -163.61 | 369.16 |
|
Provision for Tax
|
-0.13 | 210.30 | 119.90 | -21.58 | 94.17 |
|
Profit after Tax (Net Income)
|
-43.51 | 621.00 | 378.70 | -142.03 | 274.99 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | 0.00 |
|
Consolidated Profit
|
0.00 | 271.90 | 0.00 | 0.00 | 140.99 |
Liabilities ($ Mln)
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
-16.29 | 2,597.70 | 2,441.69 | 324.07 | 830.51 |
|
Minority Interest
|
0.00 | -212.30 | -0.33 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
105.16 | 3,123.00 | 2,419.29 | 1,821.51 | 429.23 |
|
Current Liabilities
|
79.35 | 873.40 | 884.80 | 1,483.23 | 319.85 |
|
Total Liabilities
|
164.66 | 7,089.70 | 5,462.97 | 2,154.71 | 1,640.01 |
Assets ($ Mln)
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
51.37 | 6,416.50 | 4,677.91 | 2,244.20 | 1,288.35 |
|
Current Assets
|
116.86 | 1,041.00 | 1,071.49 | 1,384.61 | 291.24 |
|
Total Assets
|
164.66 | 7,089.70 | 5,462.97 | 2,154.71 | 1,640.01 |
|
Total Debt*
|
104.86 | 2,842.30 | 2,250.35 | 1,546.24 | 329.09 |
|
Net Current Assets
|
37.51 | 167.60 | 186.69 | 0.00 | 0.00 |
Cashflow ($ Mln)
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-24.59 | 1,175.60 | 564.27 | 300.01 | 388.27 |
|
Cash Flow from Investing Activities
|
-3.07 | -762.80 | -513.18 | -1,024.96 | -59.34 |
|
Cash from Financing Activities
|
11.56 | -433.00 | -11.81 | 729.62 | -432.77 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-56.45 | 11.40 | 6.75 | 11.94 | 22.16 |
|
ROE (%)
|
999.19 | 16.23 | 16.18 | -32.84 | 30.39 |
|
ROA (%)
|
-18.47 | 7.77 | 6.15 | -3.97 | 14.28 |
|
EBIT Margin (%)
|
-6.60 | 18.59 | 9.24 | -6.35 | 14.08 |
|
Net Margin (%)
|
-7.97 | 10.01 | 6.90 | -5.51 | 10.60 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
35.37 | 9.47 | 18.89 | 28.04 | 3.31 |
|
EBIT Growth (%)
|
32.42 | 16.43 | 17.37 | -217.51 | -6.25 |
|
Net Profit Growth (%)
|
32.39 | 18.81 | 17.32 | -173.36 | -5.29 |
|
EPS Growth (%)
|
94.69 | 20.05 | 15.72 | -179.07 | 1.50 |
|
Book Value Growth (%)
|
-124.33 | 16.44 | 19.22 | -36.19 | -24.60 |
Valuation Ratios
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-59.60 | 19.12 | 30.03 | 62.76 | 22.57 |
|
Price / Book Value
|
-229.76 | 4.44 | 4.63 | 14.89 | 6.11 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-86.60 | 9.54 | 24.49 | 48.19 | 14.37 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-4.83 | 1.00 | 0.06 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
-0.45 | 0.02 | 0.05 | 0.04 | 0.09 |
|
Current Ratio
|
1.47 | 1.19 | 1.21 | 0.93 | 0.91 |
|
Quick Ratio
|
1.17 | 1.19 | 1.21 | 0.87 | 0.89 |
|
Interest Coverage
|
-4.71 | 9.18 | 65.04 | -- | 77.54 |
Operating Efficiency Ratios
| Oncology Institute Inc (TOI) | Encompass Health Corp (EHC) | The Ensign Group (ENSG) | Hims Hers Health Inc (HIMS) | Chemed Corp (CHE) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
10.89 | 11.07 | 12.19 | 14.56 | 7.27 |
|
Asset Turnover
|
2.32 | 0.78 | 0.89 | 0.72 | 1.35 |
|
Receivable days
|
39.23 | 37.48 | 43.58 | 2.97 | 25.53 |
|
Inventory Days
|
11.53 | -- | -- | 53.56 | 1.62 |
|
Payable days
|
28.91 | 250.68 | 8.42 | 69.71 | 10.06 |
|
Cash Conversion Cycle
|
21.85 | -- | -- | -13.17 | 17.10 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
